Latest Insider Transactions at Better For You Wellness, Inc. (BFYW)
This section provides a real-time view of insider transactions for Better For You Wellness, Inc. (BFYW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Better For You Wellness, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Better For You Wellness, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 24
2023
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+3.84%
|
$0
$0.01 P/Share
|
|
May 16
2023
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+1.17%
|
$0
$0.01 P/Share
|
|
May 10
2023
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+1.19%
|
$0
$0.01 P/Share
|
|
Apr 17
2023
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+8.88%
|
$0
$0.01 P/Share
|
|
Mar 30
2023
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+25.75%
|
$0
$0.01 P/Share
|
|
Mar 30
2023
|
Stephen James Letourneau Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+47.14%
|
$0
$0.01 P/Share
|
|
Mar 29
2023
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+4.14%
|
-
|
|
Mar 29
2023
|
Christina Jefferson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+16.67%
|
-
|
|
Mar 29
2023
|
Joseph J. Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+7.69%
|
-
|
|
Mar 29
2023
|
Montel Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+12.5%
|
-
|
|
Mar 24
2023
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
126,000
+21.83%
|
$0
$0.01 P/Share
|
|
Dec 01
2022
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+4.32%
|
-
|
|
Dec 01
2022
|
Joseph J. Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+8.33%
|
-
|
|
Dec 01
2022
|
Christina Jefferson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.0%
|
-
|
|
Dec 01
2022
|
Montel Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+14.29%
|
-
|
|
Oct 27
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+23.52%
|
$0
$0.03 P/Share
|
|
Oct 19
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.1%
|
$0
$0.02 P/Share
|
|
Oct 17
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+1.55%
|
$0
$0.02 P/Share
|
|
Oct 14
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+4.36%
|
$0
$0.02 P/Share
|
|
Oct 13
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+6.69%
|
$0
$0.02 P/Share
|
|
Oct 12
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+2.51%
|
$0
$0.02 P/Share
|
|
Oct 11
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+1.05%
|
$0
$0.02 P/Share
|
|
Oct 10
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,000
+25.48%
|
$0
$0.02 P/Share
|
|
Oct 07
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,000
+17.64%
|
$0
$0.03 P/Share
|
|
Sep 29
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+6.31%
|
$0
$0.02 P/Share
|
|
Sep 28
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,831
+29.41%
|
$0
$0.02 P/Share
|
|
Sep 01
2022
|
Montel Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+16.67%
|
-
|
|
Sep 01
2022
|
Joseph J. Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+9.09%
|
-
|
|
Sep 01
2022
|
Christina Jefferson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.0%
|
-
|
|
Sep 01
2022
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+4.51%
|
-
|
|
Jul 12
2022
|
Montel Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.0%
|
-
|
|
Jul 12
2022
|
Joseph J. Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+10.0%
|
-
|
|
Jul 12
2022
|
Christina Jefferson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
-
|
|
Jul 12
2022
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+4.73%
|
-
|
|
Jun 22
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,094
+20.0%
|
$0
$0.12 P/Share
|
|
Jun 17
2022
|
Stephen James Letourneau Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,094
+25.0%
|
$0
$0.12 P/Share
|
|
Jun 16
2022
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,094
+25.0%
|
$0
$0.12 P/Share
|
|
Apr 12
2022
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+4.96%
|
-
|
|
Apr 12
2022
|
Nicola Finley Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.0%
|
-
|
|
Apr 12
2022
|
Joseph J. Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.11%
|
-
|
|
Apr 12
2022
|
Montel Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.0%
|
-
|
|
Jan 03
2022
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+5.22%
|
-
|
|
Jan 03
2022
|
Nicola Finley Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
-
|
|
Jan 03
2022
|
Joseph J. Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+12.5%
|
-
|
|
Jan 03
2022
|
Leslie Bumgarner Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
-
|
|
Jan 03
2022
|
Montel Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
-
|
|
Dec 20
2021
|
Joseph J. Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+45.45%
|
$0
$0.12 P/Share
|
|
Dec 14
2021
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
403,747
+48.5%
|
$0
$0.12 P/Share
|
|
Dec 13
2021
|
Ian Andrew James Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,188
+50.0%
|
$0
$0.12 P/Share
|
|
Dec 13
2021
|
Stephen James Letourneau Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,187
+50.0%
|
$0
$0.12 P/Share
|